Use of cilostazol in percutaneous coronary interventions.

Use of cilostazol in percutaneous coronary interventions.

Item
http://www.wikidata.org/entity/Q38016384
Comparing the effectiveness and safety between triple antiplatelet therapy and dual antiplatelet therapy in type 2 diabetes mellitus patients after coronary stents implantation: a systematic review and meta-analysis of randomized controlled trialsComparison of cilostazol versus ticlopidine following coronary stenting in patients with coronary heart disease: A meta-analysis of randomized controlled trialsEfficacy and safety of cilostazol based triple antiplatelet treatment versus dual antiplatelet treatment in patients undergoing coronary stent implantation: an updated meta-analysis of the randomized controlled trials.Clinical efficacy and safety of cilostazol: a critical review of the literature.The pharmacokinetic and pharmacodynamic interaction of clopidogrel and cilostazol in relation to CYP2C19 and CYP3A5 genotypes.Tailoring antiplatelet therapy in acute coronary syndromes: the thin red line.Phosphodiesterase-3 inhibition augments the myocardial infarct size-limiting effects of exenatide in mice with type 2 diabetes.
P2860

Use of cilostazol in percutaneous coronary interventions.

Item
http://www.wikidata.org/entity/Q38016384
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Use of cilostazol in percutaneous coronary interventions.
@en
type
label
Use of cilostazol in percutaneous coronary interventions.
@en
prefLabel
Use of cilostazol in percutaneous coronary interventions.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P356
P1433
P1476
Use of cilostazol in percutaneous coronary interventions.
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698